Tag Archives: 2028 Workplan

EMA and HMAs Announce 2028 Workplan to Harness Artificial Intelligence in Medicines Regulation

(IN BRIEF) The European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMAs) have jointly released a comprehensive Artificial Intelligence (AI) workplan outlining their collaborative strategy through 2028. This initiative aims to maximize the benefits of AI for stakeholders … Read the full press release